PMID: 590698Jan 1, 1977

Diagnosis of pancreatic cancer by endoscopic retrograde cholangiopancreatography and pancreozymin secretin test

Gastroenterologia Japonica
S NakanoM Nakamura

Abstract

Eighy cases with carcinoma of the pancreas were divided into 10 groups according to the location and size of the tumor. Drip infusion cholangiography, percutaneous transphepatic cholangiography, hypotonic duodenography and endoscopic retrograde cholangiopancreatography were employed for this classification. Comparison of cholangiopancreatograms (ERCP) with results of the biliary and pancreatic secretory function assessed by pancreozymin secretin test (PS test clarifies secretory capacity of the exocrine pancreas. But combination of ERCP and PS test with cytology is necessary for the correct diagnosis of the pancreatic cancer and it is hoped that the combination may excavate the disease in the early stage.

References

Sep 1, 1959·The British Journal of Surgery·M BIRNSTINGL

Citations

Jul 1, 1986·The British Journal of Surgery·N H GilinskyI N Marks

Related Concepts

Biliary Sludge
Cholangiography
CCK-33
Surgical Endoscopy
Study, Methodological
Pancreas
Malignant Neoplasm of Pancreas
Secrepan

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.